⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPTI News
Karyopharm Therapeutics Inc.
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Announces $30 Million Private Placement with RA Capital
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Registration Momentum Builds Across the Oncology Pipeline
globenewswire.com
ACRV
KPTI
ERAS
ONCY
INCY
Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
prnewswire.com
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI